Polymorphisms of adiponectin and resistin genes in patients with obesity and anorexia nervosa;Polymorfismy genů pro adiponectin a rezistin u pacientek s mentální anorexií a obezitou - Pilotní studie

Casopis Lekaru Ceskych

Volumn 145, Issue 7, 2006, Pages 562-566

  Dolinková, Markéta ^a,b   Krizova J ^a   Lacinova Z ^a   Dolezalova R ^a   Housova J ^a   Krajickova J ^a   Bosanska L ^a   Papezova H ^a   Haluzik M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b lékarské fakulty UK a VFN   (Czech Republic)

Author keywords

Adiponectin; Anorexia nervosa; Obesity; Polymorphism; Resistin

Indexed keywords

ADIPONECTIN; INSULIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ALLELE; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OBESITY; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 33747619636     PISSN: 00087335     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arita, Y., Kihara, S., Ouchi, N. et al.: Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, s. 79-83.
2. Hotta, K., Funahashi, T., Arita, Y. et al.: Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol., 2000, 20, s. 1595-1599.
3. Berg, A. H., Combs, T. P., Du, X. et al.: The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat. Med., 2001, 7, s. 947-953.
4. Kubota, N., Terauchi, Y., Yamauchi, T. et al.: Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem., 2002, 277, s. 25863-25866.
5. Steppan, C. M., Bailey, S. T., Bhat, S. et al.: The hormone resistin links obesity to diabetes. Nature, 2001, 409, s. 307-312.
6. Kim, K. H., Lee, K., Moon, Y. S., Sul, H. S.: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem., 2001, 276, s. 11252-11256.
7. Rajala, M. W., Obici, S., Scherer, P. E., Rossetti, L.: Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J. Clin. Incest., 2003, 111, s. 225-230.
8. Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E. et al.: Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab., 2003, 88, s. 5452-5455.
9. Lee, J. H., Chan, J. L., Yiannakouris, N. et al.: Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab., 2003, 88, s. 4848-4856.
10. Hara, K., Boutin, P., Mori, Y. et al.: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes., 2002, 51, s. 536-540.
11. Fredriksson, J., Carlsson, E., Orho-Melander, M. et al.: A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects. Int. J. Obes. (Lond.), 2006, 30, s. 226-232.
12. Gonzalez-Sanchez, J. L., Zabena, C. A., Martinez-Larrad, M. T. et al.: An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes. Res., 2005, 13, S. 807-812.
13. Filippi, E., Sentinelli, F., Trischitta, V. et al.: Association of the human adiponectin gene and insulin resistance. Eur. J. Hum. Genet., 2004, 12, s. 199-205.
14. Menzaghi, C., Ercolino, T., Di Paola, R. et al.: A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes, 2002, 51, s. 2306-2312.
15. Yang, W. S., Tsou, P. L., Lee, W. J. et al.: Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J. Mol. Med., 2003, 81, s. 428-434.
16. Bouchard, L., Weisnagel, S. J., Engert, J. C. et al.: Human resistin gene polymorphism is associated with visceral obesity and fasting and oral glucose stimulated C-peptide in the Quebec Family Study. J. Endocrinol. Invest., 2004, 27, s. 1003-1009.
17. Conneely, K. N., Silander, K., Scott, L. J. et al.: Variation in the resistin gene is associated with obesity and insulin-related phenotypes in Finnish subjects. Diabetologia, 2004, 47, s. 1782-1788.
18. Mattevi, V. S., Zembrzuski, V. M., Hutz, M. H.: A resistin gene polymorphism is associated with body mass index in women. Hum. Genet., 2004, 115, s. 208-212.
19. Cho, Y. M., Youn, B. S., Chung, S. S. et al.: Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia, 2004, 47, s. 559-565.
20. Tan, M. S., Chang, S. Y., Chang, D. M. et al.: Association of resistin gene 3′-untranslated region +62G→A polymorphism with type 2 diabetes and hypertension in a Chinese population. J. Clin. Endocrinol. Metab., 2003, 88, s. 1258-1263.
21. Gouni-Berthold, I., Giannakidou, E., Faust, M. et al.: Resistin gene 3′-untranslated region +62G→A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population. J. Intern. Med., 2005, 258, s. 518-526.
22. Smith, S. R., Bai, F., Charbonneau, C. et al.: A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes, 2003, 52, s. 1611-1618.
23. Delporte, M. L., Brichard, S. M., Hermans, M. P. et al.: Hyperadiponectinaemia in anorexia nervosa. Clin. Endocrinol. (Oxf)., 2003, 58, s. 22-29.
24. Brichard, S. M., Delporte, M. L., Lambert, M.: Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm. Metab. Res., 2003, 35, s. 337-342.
25. Housova, J., Anderlova, K., Krizova, J. et al.: Serum adiponectin and resistin concentrations in patients with restrictive and binge/purge form of anorexia nervosa and bulimia nervosa. J. Clin. Endocrinol. Metab., 2005, 90. s. 1366-1370.
26. Engert, J. C., Vohl, M. C., Williams, S. M. et al.: 5′ flanking variants of resistin are associated with obesity. Diabetes, 2002, 51, s. 1629-1634.
27. Xita, N., Georgiou, I., Tsatsoulis, A. et al.: A polymorphism in the resistin gene promoter is associated with body mass index in women with polycystic ovary syndrome. Fertil. Steril., 2004, 82, s. 1466-1467.